Popular
SyVento BioTech is a biotechnology company that provides end-to-end solutions for the development of lipid-based nanocarriers and lipid nanoparticle (LNP) technologies.
Description
SyVento BioTech is an innovative biotech CDMO offering end-to-end capabilities to develop, manufacture, and formulate next-generation mRNA-based products and innovative medicines. With a state-of-the-art facility located in the EU (Poland), the company specializes in liposomal and LNP technology, providing tailored solutions for the encapsulation and delivery of therapeutic molecules, including small molecules, RNA, DNA, and proteins.
Leveraging unique know-how and customer-centric flexibility, SyVento BioTech delivers comprehensive services, including preclinical/clinical drug development, RUO/GMP-grade API production, the manufacturing of commercial and clinical batches, and sterile fill & finish—all under one roof.
Type of Drugs Manufactured:
Small Molecule;Biologics;Cell & Gene Therapy
CDMO Services:
Drug Substance Manufacturing (API);Drug Product Formulation (FDF);Aseptic Fill Finish;Research & Development;Clinical Trials materials and logistics;Packaging;Regulatory Services;Analytical Development
No. of Manufacturing Facilities:
1
High Potent Products capabilities:
OEB 3
Facilities Locations:
Europe
Regulatory Approvals for facilities:
EMA (Europe)
Manufacturing Technologies:
Cartridges;Liquids;Pre-Filled Syringes (PFS);Sterile Vials
Current Capacity:
We are very flexible in terms of capacity securing demand from low scale dedicated to clinical purpose to large commercial scale production. Our production capacity allows us to produce 36 million doses of Covid-19 vaccine based on mRNA technology.
SyVento BioTech guarantees short term of manufacturing projects realization. Majority, we are able to start the project as soon as the terms and conditions are agreed.
Contact Information
Website
Latest News
